A case study of a patient with MEN1 mosaicism showed that ccfDNA from thymic variants were detected a month before the relapse of TNET, showing that the TNET was growing, and ccfDNA was suggested as a potential early tumor marker [123]. The gene discussed is MEN1; the disease is neoplasm.